TherapeuticsMD Announces Oral Presentation Of Positive Phase 2 And Bioavailability Data On TX-004HR (VagiCapTM)
October 15, 2014 at 16:32 PM EDT
TherapeuticsMD Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, announced today that positive results from phase 2 and ...